lentiviral gene therapy for drug resistant epilepsy

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 26 Oct 2020: Trial registered, NCT04601974

The trials

NCT04601974: Lentiviral Gene Therapy for Epilepsy

State
Not started
Phase
Phase 1 and Phase 2
People
10 planned
Started
Sep 2024
Primary completion
Sep 2028
Arms
lentiviral gene therapy treatment (Intervention Arm)
Results
None posted
  1. 26 Oct 2020: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Gene therapy.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.